Thursday, October 15, 2026

Is The Market Turning The Page?

CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.

CRWV $34B

WHAT ARE WE DOING? “Contrarians At The Gate” Oct 15 51 clicks

Oct 15 APP $88B

AppLovin Deep Dive

Speedwell Research 25 clicks

Oct 15 STZ $22B

Constellation: Stars Aligning?

TSOH Investment Research 27 clicks

From X

@majgeoinvesting Sep 17

Maj Soueidan on X

I can see that being true. But when you’re playing in the smaller cap universe, the information disconnect edge is crazy huge. Because less investors are looking at these stocks, no one‘s really finding the information. But yes, when people discover the info, the interpretation phase kicks in. With big caps it’s more about the interpretation phase because everyone is looking at the same information. With microcaps, you have two MultiBagger forces happening: Early information discovery + interpretation. By the way, let’s not forget that there’s so much information out there to interpret, that it creates “brain” overload. It’s going to be interesting to see how AI plays a part in solving some of that problem. 👊But generally, I do like your interpretation angle. It’s funny because when you find information arbitrage in microcaps… that’s so obvious… sometimes you have no movement in the stock because people are either interpreting it wrongly or just don’t believe it, etc. By the way, $HPE would be another good Bigcap Case Study you could use to support your interpretation argument. It just sat there at 15 bucks, as people debated their relevance in AI… And then overnight it goes to $50. I rarely buy big caps, but I got lucky and actually bought some call options ahead of the move.

@ACapitalLP Sep 17

A Capital on X

This is actually a great point. $QXO is an opportunistic acquisition vehicle, not a plain vanilla building products company like $BLDR. If it’s just trading with rates, that could be the opportunity… https://t.co/yhGuyFWQAT

@ACapitalLP Sep 17

A Capital on X

Did you see $OWL dip below $10 again yesterday? Even in a pretty draconian case, this thing is worth ~$9 at ~14x FY27 FRE (upside is $15+). Credit remains stable, redemptions are moderating, fundraising is strong and AI infrastructure demand isn’t slowing… That’s asymmetric opportunity.

@BlueDuckCap Sep 16 3 clicks

BDC on X

Idk it not worth nothing. Snap whole market cap $9b and yet we apparently paying trillions for commoditized “frontier” LLMs that are political nightmares with major leadership questions. $snap is cheap. Specs will get a minority investor. Snap snap can do $1 in FCF / share next year. Consensus is always wrong at these moments.

@red_dog_capital Sep 16

Red Dog Capital on X

Just migrated my wife from @evernote to @joplinapp because @bendingspoons $BSP is a predatory company that price gouges old consumer apps. They make everything hard to do (on purpose) because $BSP is a scam company. @FTC @OIGFedCFPB

@BlueDuckCap Sep 16 2 clicks

BDC on X

Maybe this earlier post is hyperbolic. But Specs potential is real and the applications are very real and the implied value to $snap is negative. Btw go back and look at all my snap tweets - been as big a bear as any of you. But the worm is turning. Sub business 85% yy $1b+ rr and ads stable and 16% HC reduction to cut $500mn opex and SBC offset by buyback. So there’s a lot to like here and if specs can get a minority investor which i think is much more likely after today then game on. Oh and by the way snap could still cut opex by 50% just to get in line with $rddt on cost/employee.

@BarbarianCap Sep 16

Barbarian Capital on X

Generac’s stock soars more than 30% after Amazon deal cements company’s status as an AI-power player $GNRC https://t.co/fwN8XLPiKY

@BarbarianCap Sep 16

Barbarian Capital on X

J.B. Hunt stock plunges 13% after company warns third-quarter earnings will fall $JBHT https://t.co/Um7V5QhpjP

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI…

CMG $39B

Yet Another Value Podcast Oct 14 87 clicks

Everyone wants to defend CoreWeave but who really knows

CoreWeave faces fresh skepticism as another AI trade selloff collides with bullish defenses of the company.

CRWV $34B

The Technology Letter Oct 14 6 clicks

A Conversation With Ari Emanuel About Entertainment and AI

Ari Emanuel discusses AI’s impact on Hollywood, live events, social networks and the future of advertising.

TKO $33B

Stratechery by Ben Thompson – On the business, strategy, and impact of technology. Oct 14 7 clicks

Coherent | Management Call

COHR $52B

P Equity Research Oct 14 18 clicks

First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor

First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…

TEVA $48B

Equity Eagle Oct 14 8 clicks

Research Roundup Vol. LVI

Howmet Aerospace is framed as a beneficiary of turbine and aircraft-engine demand, while J.B.

HWM $88BJBHT $22B

Monte Independent Investment Research Oct 14 14 clicks

Lennar: The Misstep Is Temporary, the Operating Machine Is Not

Lennar cut build times to 116 days and adopted an asset-light land model, while gross margin fell to 15.8% from 27.5% as land costs rose.

LEN $17B

Latticework by MOI Global Oct 14 14 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $17B

Latticework by MOI Global Oct 14 15 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $17B

Latticework by MOI Global Oct 14 13 clicks

Insider activity September 2026

Asian insider buying rose 19% to US$2.4 billion across 930 September transactions, led by Grab CEO Anthony Tan’s US$30 million purchase…

GRAB $12B

Asian Century Stocks Oct 14 6 clicks

Rollins (ROL), Verisure (VSURE), and the cost of standing still (Part 2, Verisure)

Verisure’s 6.38 million monitored-alarm subscribers generate 90% recurring revenue, while its disclosed acquisition costs and 6%-8% churn…

ROL $15B

Best Anchor Stocks Oct 13 24 clicks

BridgeBio: Maintaining 'Strong Buy' Additional Encaleret Data ADH1 And Three Expected FDA Reviews

BridgeBio Pharma reported Q2 revenue of $243.7 million and has three Priority Review NDAs, while $1 billion in convertible preferred…

BBIO $13B

Terry Chrisomalis Oct 13 2 clicks

AMADF · long

Amadeus It Group SA

Amadeus IT Group turns long after shares fell more than 20% since a November short call.

AMADF $25B

Value Investors Club Jul 15 1 click

Expectations going higher for Everpure, DigitalOcean

Everpure and DigitalOcean face rising expectations as their stock prices shape Monday’s views.

DOCN $13B

The Technology Letter Oct 12 7 clicks

Vicor Update, Part Two

Vicor uses ITC exclusion-order cases to license power-module patents, with published royalty multipliers rising from 1.0x before filing to…

VICR $10B

CV's Substack Oct 12 4 clicks

Rubrik (NYSE: RBRK) Stock Rating: DISTRIBUTE After Q2 FY1/27 Earnings

Rubrik posted 38% Q2 revenue growth to $427.3 million, but Cloud ARR growth slowed to 39% and its enterprise value reached 15.7 times…

RBRK $25B

Cestrian Capital Research Oct 12 4 clicks

Expert Call | Nebius

Nebius’s 1 GW annual active-capacity target from 2027 is realistic, according to a former product manager, with greenfield data centers…

NBIS $56B

P Equity Research Oct 12 4 clicks

Q3 2026 Jenga IP Quarterly Letter

Jenga Global Master Fund returned 8.10% in Q3 2026, added Adobe and Mexican airports, and later initiated S&P Global.

ADBE $98B

Global Outperformers Oct 12 3 clicks

Howmet Aerospace: Strong Q2, But The Valuation Is Too Rich

Howmet Aerospace posted 24% Q2 revenue growth and 46% adjusted EPS growth, but HWM trades about 87% above a $120.69 DCF fair-value estimate.

HWM $88B

Alexander I. Velasquez Oct 12 2 clicks

LQDA: finer powder, higher doses

Liquidia’s Yutrepia sales reached $170.4 million in Q2 2026, while a patent ruling threatens its PH-ILD label but leaves PAH sales and a…

UTHR $24B

Trade Ideas Flow Oct 12 4 clicks

Thursday, October 15, 2026

Maj Soueidan on X

A Capital on X

A Capital on X

BDC on X

Red Dog Capital on X

BDC on X

Barbarian Capital on X

Barbarian Capital on X

Investor Letters

Publications we follow

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 52 of 236

X accounts we follow

Investor letters we follow

Sectors